Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-22T12:41:04.588Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuromuscular effects of rapacuronium on the diaphragm and skeletal muscles in anaesthetized patients using cervical magnetic stimulation for stimulating the phrenic nerves

Published online by Cambridge University Press:  16 August 2006

O. Moerer ,
C. Baller ,
J. Hinz ,
H. Buscher  and
T. A. Crozier
O. Moerer
Affiliation:
Universität Göttingen, Zentrum Anaesthesiologie, Rettungs- und Intensivmedizin, Göttingen, Germany
C. Baller
Affiliation:
Universität Göttingen, Zentrum Anaesthesiologie, Rettungs- und Intensivmedizin, Göttingen, Germany
J. Hinz
Affiliation:
Universität Göttingen, Zentrum Anaesthesiologie, Rettungs- und Intensivmedizin, Göttingen, Germany
H. Buscher
Affiliation:
Universität Göttingen, Zentrum Anaesthesiologie, Rettungs- und Intensivmedizin, Göttingen, Germany
T. A. Crozier
Affiliation:
Universität Göttingen, Zentrum Anaesthesiologie, Rettungs- und Intensivmedizin, Göttingen, Germany
Get access

Abstract

Background and objective: Non-depolarizing neuromuscular blocking agents have a shorter duration of action on the diaphragm than on skeletal muscles. It was to be tested if this also held true for rapacuronium, a shortacting, amidosteroid non-depolarizing neuromuscular blocker, lately withdrawn from the market, using a novel technique for stimulating the diaphragm and assessing its function.

Methods: Anaesthesia was induced with propofol 2 mg kg−1 and remifentanil 1 μg kg−1, and the trachea was intubated after topical anaesthesia. Rapacuronium was given at a dose of 1.5 mg kg−1. The diaphragm was stimulated by cervical magnetic stimulation of the phrenic nerves (2 Tesla, single coil) and airway pressure responses were measured at the endotracheal tube connector. The neuromuscular effects at the adductor pollicis and orbicularis oculi muscles were measured by acceleromyography.

Results: Fifteen males and five females (ASA I and II; 27 ± 8 yr; 73 ± 13 kg; mean ± SD) were recruited. Median maximal relaxation was less (P < 0.01) for the diaphragm (89%) than for the adductor pollicis or orbicularis oculi muscles (each 100%). The time to 25% recovery was shorter for the diaphragm than for adductor pollicis or orbicularis oculi (7.5 ± 3.1 versus 14.1 ± 3.7 and 15.1 ± 3.5 min, respectively, P < 0.01). Recovery from 25 to 75% was identical for the diaphragm and adductor pollicis (9.4 ± 2.9 versus 9.1 ± 3.5 min), but longer for orbicularis oculi (13.4 ± 4.2 min, P < 0.01). The median recovery time to TOF0.8 was shorter for the diaphragm (23.9 min) than for the adductor pollicis or orbicularis oculi muscles (31.5 and 28.4 min, respectively; P < 0.05).

Conclusions: As with other non-depolarizing muscle relaxants, the duration of the clinical effect of rapacuronium was shorter for the diaphragm than for skeletal muscle. The recovery index was identical for the diaphragm and adductor pollicis.

Keywords

neuromuscular non-depolarizing agentsrapacuroniumrespiratory musclesdiaphragm
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 19 , Issue 12 , December 2002 , pp. 883 - 887
Copyright
2002 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)